Ledger.Open graph →
SEC Form D · filed September 23, 2014

Axsome Therapeutics, Inc

Offering
$7.5M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Tad O'Donnell · Minneapolis, MNExec · DirectorRick R. Lee · Owings Mills, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗